Diodes Inc /Del/
DIOD Nasdaq Semiconductors & Related Devices Financials FY2016βFY2025
What Diodes Inc /Del/ does
No business description yet.
- Legal name
- DIODES INC /DEL/
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 10, 2026
- Accession Β· CIK
- 0001193125-26-044918
0000029002
Revenue and margins
Diodes Inc /Del/ had $1.5B of revenue in fiscal 2025, up 13.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 18.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $137M in fiscal 2025, 9.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Diodes Inc /Del/ returned $33.8M to shareholders in fiscal 2025, 25% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Diodes Inc /Del/ can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $370M | $344M | $326M | $316M | $377M |
| Debt incl. finance leases | $285M | $150M | $21.5M | $20.8M | $25.8M |
| Net debt / EBITDA | β0.2x | β0.4x | β0.8x | β1.7x | β2.2x |
| Debt / equity | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 36.8x | 49.1x | 44.0x | 21.6x | 12.8x |
| Current ratio | 2.5x | 2.7x | 3.0x | 3.3x | 3.3x |
| Quick ratio | 1.8x | 1.9x | 2.0x | 2.0x | 2.1x |
| Total assets | $2.2B | $2.3B | $2.4B | $2.4B | $2.4B |
| Total liabilities | $892M | $705M | $558M | $517M | $510M |
| Shareholders' equity | $1.2B | $1.5B | $1.7B | $1.8B | $1.9B |
| Net debt (β = net cash) | β$85.1M | β$193M | β$304M | β$295M | β$351M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 9 | 8 / 9 | 6 / 9 | 3 / 9 | 9 / 9 | 8 / 9 | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β7.1% | β12.1% | β5.4% | β4.8% | β4.9% | β5.3% | β2.7% | β2.3% | β3.2% | β6.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $942M | $1.1B | $1.2B | $1.2B | $1.2B | $1.8B | $2.0B | $1.7B | $1.3B | $1.5B |
| Gross profit | $287M | $357M | $435M | $466M | $431M | $670M | $827M | $658M | $436M | $462M |
| Research and development | $69.9M | $77.9M | $86.3M | $88.5M | $94.3M | $119M | $126M | $135M | $134M | $162M |
| Operating income | $38.0M | $79.4M | $154M | $201M | $134M | $276M | $408M | $251M | $50.5M | $35.5M |
| Interest expense | $13.3M | $13.4M | $9.9M | $7.9M | $11.7M | $7.5M | $8.3M | $5.7M | $2.3M | $2.8M |
| Pretax income | $25.0M | $62.6M | $150M | $198M | $120M | $315M | $396M | $278M | $62.7M | $84.0M |
| Income tax | $6.6M | $62.3M | $44.6M | $44.1M | $21.1M | $78.8M | $56.7M | $47.3M | $11.8M | $14.8M |
| Net income | $15.9M | β$1.8M | $104M | $153M | $98.1M | $229M | $331M | $227M | $44.0M | $66.1M |
| Diluted EPS | $0.32 | β$0.04 | $2.04 | $2.96 | $1.88 | $5.00 | $7.20 | $4.91 | $0.95 | $1.43 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $125M | $181M | $186M | $230M | $187M | $339M | $393M | $281M | $119M | $216M |
| Capital expenditure | $58.5M | $111M | $87.5M | $98.5M | $75.8M | $141M | $212M | $151M | $73.0M | $78.4M |
| Free cash flow | $66.2M | $70.0M | $98.1M | $131M | $111M | $197M | $181M | $130M | $46.4M | $137M |
| Depreciation and amortization | $78.5M | $76.9M | $86.3M | $91.5M | $91.7M | $106M | $112M | $122M | $121M | $122M |
| Stock-based compensation | $14.0M | $18.6M | $20.7M | $20.5M | $25.3M | $33.2M | $36.3M | $30.9M | $22.8M | $25.7M |
| Acquisitions | β | β | $0.0M | $33.0M | $24.6M | $0.2M | $84.0M | $0.0M | $56.7M | $5.3M |
| Share buybacks | $18.0M | $8.7M | β | β | $297M | $0.0M | $0.0M | $0.0M | $0.0M | $33.8M |
| Dividends and buybacks | $18.0M | $8.7M | β | β | $297M | $0.0M | $0.0M | $0.0M | $0.0M | $33.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $278M | $208M | $249M | $263M | $274M | $370M | $344M | $326M | $316M | $377M |
| Total debt | $430M | $270M | $215M | $112M | $312M | $285M | $150M | $21.4M | $20.7M | $25.7M |
| Finance lease liabilities | β | β | β | $1.0M | $0.2M | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M |
| Current assets | $733M | $662M | $735M | $810M | $1.0B | $1.2B | $1.2B | $1.2B | $1.2B | $1.3B |
| Current liabilities | $185M | $247M | $254M | $285M | $510M | $471M | $433M | $393M | $376M | $378M |
| Inventory | $193M | $217M | $215M | $236M | $307M | $349M | $360M | $390M | $475M | $472M |
| Property and equipment, net | $402M | $459M | $447M | $470M | $531M | $582M | $737M | $746M | $684M | $650M |
| Goodwill | $129M | $134M | $132M | $141M | $158M | $150M | $145M | $147M | $182M | $183M |
| Intangible assets | $175M | $156M | $138M | $120M | $111M | $94.6M | $79.1M | $63.9M | $67.4M | $45.5M |
| Total assets | $1.5B | $1.5B | $1.5B | $1.6B | $2.0B | $2.2B | $2.3B | $2.4B | $2.4B | $2.4B |
| Total liabilities | $708M | $615M | $549M | $487M | $963M | $892M | $705M | $558M | $517M | $510M |
| Preferred stock | β | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $776M | $832M | $931M | $1.1B | $964M | $1.2B | $1.5B | $1.7B | $1.8B | $1.9B |
| Margins | ||||||||||
| Gross margin | 30.5% | 33.8% | 35.9% | 37.3% | 35.1% | 37.1% | 41.3% | 39.6% | 33.2% | 31.2% |
| Operating margin | 4.0% | 7.5% | 12.7% | 16.1% | 10.9% | 15.3% | 20.4% | 15.1% | 3.8% | 2.4% |
| EBITDA margin | 12.4% | 14.8% | 19.8% | 23.4% | 18.4% | 21.2% | 26.0% | 22.4% | 13.0% | 10.6% |
| Net margin | 1.7% | β0.2% | 8.6% | 12.3% | 8.0% | 12.7% | 16.6% | 13.7% | 3.4% | 4.5% |
| FCF margin | 7.0% | 6.6% | 8.1% | 10.5% | 9.1% | 10.9% | 9.0% | 7.8% | 3.5% | 9.3% |
| Returns | ||||||||||
| Return on capital | 3.0% | 5.8% | 12.1% | 16.3% | 11.1% | 18.0% | 26.5% | 14.5% | 2.7% | 1.9% |
| Return on capital employed | 2.8% | 6.4% | 12.1% | 14.8% | 9.1% | 16.0% | 22.0% | 12.7% | 2.5% | 1.7% |
| Return on equity | 2.1% | β0.2% | 11.8% | 15.0% | 9.5% | 20.8% | 24.1% | 14.0% | 2.5% | 3.6% |
| Return on assets | 1.0% | β0.1% | 6.9% | 9.7% | 5.4% | 11.0% | 14.8% | 9.8% | 1.9% | 2.7% |
| Return on tangible equity | 3.4% | β0.3% | 15.7% | 18.1% | 14.1% | 23.0% | 25.7% | 14.8% | 2.8% | 4.0% |
| Growth | ||||||||||
| Revenue growth | β | 11.9% | 15.2% | 2.9% | β1.6% | 46.9% | 10.8% | β16.9% | β21.1% | 13.0% |
| Net income growth | β | β111.3% | β | 47.3% | β36.0% | 133.2% | 44.8% | β31.4% | β80.6% | 50.2% |
| EPS growth | β | β112.5% | β | 45.1% | β36.5% | 166.0% | 44.0% | β31.8% | β80.7% | 50.5% |
| FCF growth | β | 5.7% | 40.2% | 33.9% | β15.1% | 77.1% | β8.4% | β28.0% | β64.3% | 195.5% |
| Share count change | β | β1.9% | 4.3% | 1.8% | 0.5% | β12.2% | 0.6% | 0.6% | 0.2% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.3x | 0.4x | β0.1x | β0.5x | 0.2x | β0.2x | β0.4x | β0.8x | β1.7x | β2.2x |
| Debt / equity | 0.6x | 0.3x | 0.2x | 0.1x | 0.3x | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 2.9x | 5.9x | 15.6x | 25.4x | 11.5x | 36.8x | 49.1x | 44.0x | 21.6x | 12.8x |
| Current ratio | 4.0x | 2.7x | 2.9x | 2.8x | 2.0x | 2.5x | 2.7x | 3.0x | 3.3x | 3.3x |
| Quick ratio | 2.9x | 1.8x | 2.0x | 2.0x | 1.4x | 1.8x | 1.9x | 2.0x | 2.0x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.2% | 10.5% | 7.2% | 7.9% | 6.2% | 7.8% | 10.6% | 9.1% | 5.6% | 5.3% |
| Stock comp / revenue | 1.5% | 1.8% | 1.7% | 1.6% | 2.1% | 1.8% | 1.8% | 1.9% | 1.7% | 1.7% |
| Payouts / FCF | 27.2% | 12.5% | β | β | 266.3% | 0.0% | 0.0% | 0.0% | 0.0% | 24.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 8.0 | 6.0 | 3.0 | 9.0 | 8.0 | 5.0 | 5.0 | 6.0 |
| Accruals ratio | β7.1% | β12.1% | β5.4% | β4.8% | β4.9% | β5.3% | β2.7% | β2.3% | β3.2% | β6.2% |
Source: SEC EDGAR XBRL filings (CIK 0000029002). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.